QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IMCR

QT52Immunocore Holdings plc
NASDAQ·Healthcare·Biotechnology·UK
Latest market price
28.60
+0.05+0.18%
OverviewShort InterestFilings
IMCRQT52Immunocore Holdings plc·NASDAQ
OverviewShort InterestFilings
28.60+0.18%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.38
Insider Own6.84%
Shs Outstand50.87M
Perf Week-0.07%
Market Cap1.45BForward P/E-EPS next Y-0.50Insider Trans0.12%Shs Float-Perf Month-1.14%
Enterprise Value1.43BPEG8.58EPS next Q-0.01Inst Own-Short Float-Perf Quarter-4.79%
Income-18866270.00P/S3.76EPS this Y131.42%Inst Trans-Short Ratio-Perf Half Y-21.02%
Sales385.76MP/B3.68EPS next Y-520.80%ROA-1.76%Short Interest-Perf YTD-17.60%
Book/sh7.75P/C-EPS next 5Y166.58%ROE-4.83%52W High40.71 -29.75%Perf Year-11.62%
Cash/sh16.61P/FCF-EPS past 3/5Y-ROIC-3.52%52W Low27.56 3.77%Perf 3Y-
Dividend Est.-EV/EBITDA229.83Sales past 3/5Y27.43% 58.28%Gross Margin98.81%Volatility2.19% 2.92%Perf 5Y-
Dividend TTM-EV/Sales3.72EPS Y/Y TTM47.60%Oper. Margin-7.61%ATR (14)1.17Perf 10Y-
Dividend Ex-Date-Quick Ratio4.15Sales Y/Y TTM55.65%Profit Margin-4.88%RSI (14)48.22Recom2.67
Dividend Gr. 3/5Y-Current Ratio4.18EPS Q/Q150.00%SMA20-0.48%Beta0.75Target Price46.50
Payout0.00%Debt/Eq1.11Sales Q/Q13.83%SMA50-2.40%Rel Volume2.04Prev Close28.55
Employees493LT Debt/Eq1.14EarningsAug 06SMA200-12.70%Avg Volume396.75KPrice28.60
IPO DateFeb 05, 2021Option/ShortYes / YesEPS/Sales Surpr.196.15% 0.00%Net Debt/EBITDA-2.72Volume811,108Change0.18%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-16-26DowngradeJefferiesBuy → Hold
Feb-19-26ReiteratedMizuho Securities$37 → $38
Jan-07-26ReiteratedUBS$24 → $55
Nov-10-25ReiteratedMorgan StanleyEqual Weight$35 → $36
Oct-31-25InitiatedWells FargoOverweight$60
Mar-07-25ReiteratedMorgan StanleyEqual Weight$35
Dec-13-24DowngradeMorgan StanleyOverweight → Equal Weight
Nov-11-24DowngradeMizuhoOutperform → Neutral
Oct-24-24ReiteratedUBS$24
Oct-07-24DowngradeGuggenheimBuy → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue386298248
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A566
Gross Profit381291242
Selling, General and Administrative Excl. Other152121121
Research and Development259204177
Other Operating Expense-101
Operating Income-30-34-56
Interest Expense111219
Unusual Expense
———
Non-Operating Income (Expense)-33-32-14
Net Income Before Taxes-9-14-42
Income Taxes1212-1
Consolidated Net Income-18-26-41
Net Income From Continuing Operations-18-26-41
Net Income-18-26-41
EPS (Recurring)-0.37-0.53-1.02
EPS (Basic, Before Extraordinaries)-0.37-0.53-1.02
EPS (Diluted)-0.38-0.53-1.02
EBITDA70-39
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.785.82—
Gross Margin98.7097.6597.58
Operating Margin-7.77-11.41-22.58
Net Margin-4.66-8.72-16.53
Shares Outstanding515050
Market Capitalization1,4591,736—
Operating Lease Expense
———
Insider Trading Volume
$30.93$27.83$24.74$21.65$18.55● Close Price0.00M1.20M2.41M3.61M4.81MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Berman David MHEAD OF R&DFeb 18 '26Sale32.355,965192,9685,859Feb 19 12:00 AM
Jallal BahijaCHIEF EXECUTIVE OFFICERFeb 18 '26Sale32.3511,474371,18412,343Feb 19 12:00 AM
GOLL JOHNSVP, FINANCE & CAOFeb 18 '26Sale32.3569822,580653Feb 19 12:00 AM
St Leger Tina AmberCHIEF HR OFFICERFeb 18 '26Sale32.351,00032,3501,119Feb 19 12:00 AM
Jallal BahijaCHIEF EXECUTIVE OFFICERFeb 17 '26Option Exercise0.0047,634071,453Feb 19 12:00 AM
Berman David MHEAD OF R&DFeb 17 '26Option Exercise0.0023,648035,473Feb 19 12:00 AM
GOLL JOHNSVP, FINANCE & CAOFeb 17 '26Option Exercise0.002,70204,054Feb 19 12:00 AM
St Leger Tina AmberCHIEF HR OFFICERFeb 17 '26Option Exercise0.004,23806,357Feb 19 12:00 AM
Berman David MHEAD OF R&DDec 05 '25Option Exercise17.461,14419,97411,832Dec 08 12:00 AM
Berman David MHEAD OF R&DDec 05 '25Sale40.1457222,9600Dec 08 12:00 AM
Berman David MHEAD OF R&DDec 04 '25Option Exercise17.4662,6821,094,42831,341Dec 08 12:00 AM
Berman David MHEAD OF R&DDec 04 '25Sale40.2631,3411,261,7890Dec 08 12:00 AM
Berman David MHEAD OF R&DNov 28 '25Option Exercise17.4611,042192,79443,745Dec 01 12:00 AM
Berman David MHEAD OF R&DNov 28 '25Sale40.095,521221,3370Dec 01 12:00 AM
Berman David MHEAD OF R&DNov 26 '25Option Exercise17.46138,8082,423,58869,404Dec 01 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR